Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

West Pharmaceutical Services Inc (WST.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-02-15385.37-No Rating
2022-11-29223.50250.00Neutral
2023-02-23312.03324.00Neutral
2023-04-10349.79356.00Neutral
2023-04-27355.22365.00Neutral
2023-07-10377.30400.00Neutral
2024-02-15350.70375.00Neutral
2024-04-25368.18390.00Neutral
2024-07-25277.16310.00Neutral
2024-10-24330.65350.00Neutral
2024-12-12331.62390.00Buy
2025-02-13199.11285.00Buy

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.